MeSH tree: D12.644.548
Adding the GLP-1 receptor agonist drug tirzepatide (marketed as Mounjaro) to standard care for patients with type 2 diabetes and heart disease is associated with a lower risk of a major cardiovascular event, such as a heart ...
Aug 5, 2026
0
6
Narcolepsy is a chronic neurological condition characterized by disruptions in the regulation of sleep-wake cycles. People with this condition often experience extreme sleepiness during the day and, in some cases, a sudden ...
When people are first diagnosed with a brain condition, they may not consider joining a choir to improve their well-being and regain their voice.
Aug 5, 2026
0
4
Sugar consumption has been linked to an increased risk of cavities and weight gain. In the long term, it may also contribute to insulin resistance and diabetes. For people living with asthma, however, the impact can be even ...
Aug 4, 2026
0
6
One of the many ways obesity harms the human body is through damage to skeletal muscle. This progressive muscle decline, also known as sarcopenia, reduces strength, mobility and the ability to live independently. Unfortunately, ...
Aug 4, 2026
0
20
One in eight mothers in England is now diagnosed with gestational diabetes, with diagnoses rising by 60% in just five years, according to a major study published in the journal BMJ Medicine.
Aug 4, 2026
0
4
New research has found that a hormone is responsible for making mothers' interactions with newborns feel rewarding rather than just necessary. The University of Otago—Ōtākou Whakaihu Waka study, published in Science Advances, ...
Jul 23, 2026
0
19
The use of glucagon-like peptide-1 (GLP-1) receptor agonists to treat type 2 diabetes and obesity is associated with an increased risk of hair loss (alopecia) in adults with type 2 diabetes, a study published by The BMJ finds. ...
Jul 22, 2026
0
29
Anyone who has bought medicine online may have wondered whether what arrived in the mail was really what they had paid for. They are not alone. A recent global survey found that around 60% of people fear their medicines could ...
Jul 22, 2026
0
4
Despite the end of federal shortages of popular GLP-1 weight-loss medications, the market for compounded alternatives remains strong—and some patients may unknowingly be receiving products from pharmacies with concerning ...
Jul 17, 2026
0
7
